Recognizing the World Diabetes Day, the Swedish organization Beat Diabetes has conducted a one-on-one conversation on current diabetes research between Andrzej Krolewski, MD, PhD Professor of Medicine at Harvard Medical School and Senior Investigator in Research Division, Joslin Diabetes Center, Boston, MA and Peter Jihde, Board member Beat Diabetes Foundation, TV-host, Speaker and Journalist, Sweden.
In the interview Dr. Krolewski is talking about his recent discovery of proteins that can be significant in diabetic kidney disease patients, potentially serving as prognostic biomarkers for disease progression and treatment response. The discussion is focusing on this research and future clinical applications.
Dr. Andrzej Krolewski, the head of the Genetics and Epidemiology section of the Harvard Medical School, has been working on the genetics of type 1 and type 2 diabetes. For the last 30 years, he has been actively investigating diabetic kidney disease in patient cohorts from the Joslin diabetes center.
Dr Krolewski and his team are working with the Olink technology to develop a customized panel of 21 proteins to determine which may be used to predict kidney disease development in diabetic patients, as well as to conduct further studies on patient response to treatment. This could lead to improvements into the currently limited treatments for this disease.
